Ardelyx Inc FDA Advisory Committee Update Call Transcript
Good morning, and welcome to Ardelyx conference call. (Operator Instructions) Today's conference title is FDA Advisory Committee update. (Operator Instructions) As a reminder, today's conference call is being recorded. At this time, I would like to turn the conference call over to (inaudible), Vice President, Corporate Communications and Investor Relations. You may begin.
Thank you, and good morning, everyone. Last night, we issued a press release announcing the positive outcome of the FDA and Committee meetings for XPHOZAH. During this call, we will refer to yesterday's press release, which is available on the Investors section of the company's website at ardelyx.com. .
On the call with me today with prepared remarks are Mike Raab, President and CEO; Dr. Laura Williams, Chief Medical Officer; and Susan Rodriguez, Chief Commercial Officer. Justin Renz, Chief Financial Officer; Rob Blanks; Chief Regulatory Affairs and Quality Assurance Officer; and David Rosenbaum, Chief Development Officer, will join us for the question-and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
